Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Experts and members warn HHS workforce cuts could weaken FDA oversight of device cybersecurity
Summary
Committee members and witnesses told the House subcommittee that proposed HHS and FDA staff reductions risk eroding the agency's ability to perform premarket review and postmarket cybersecurity oversight for medical devices, potentially harming patient safety and slowing innovation.
Members of the House Energy and Commerce Subcommittee pressed witnesses that reductions to HHS and FDA staffing could undermine federal oversight of medical devices and the nation's ability to detect and mitigate cybersecurity risks.
Multiple members cited the administration's announced plan to cut 20,000 positions across HHS and the prospect of removing roughly 3,500 FDA staff, and asked witnesses whether such reductions would affect device safety work. "I'm deeply alarmed by the Trump administration's announcement that the Department of Health and Human Services is DOSH's next target," Ranking Member Clark said during opening remarks, criticizing planned…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
